Abstract:This article is a clinical review of Moyamoya disease (MMD) and Moyamoya syndrome (MMS). We review the incidence, epidemiology, pathology, historical context, clinical and radiographic findings, diagnostic imaging modalities, radiographic grading systems, the effectiveness of medical, interventional, and surgical treatment, and some of the nuances of surgical treatment options. This article will help pediatricians, neurologists, neurosurgeons, and other clinical practitioners who are involved in caring for patients with this rare clinical entity. MMD is an intrinsic primary disease process that causes bilateral progressive stenosis of the anterior intracranial circulation with the involvement of the proximal portions of the intracranial internal carotid artery (ICA) extending to involve the proximal portions of the anterior cerebral artery (ACA) and middle cerebral artery (MCA); posterior circulation involvement is very rare. This causes a compensatory response where large numbers of smaller vessels such as the lenticulostriate arteries begin to enlarge and proliferate, which gives the angiographic appearance of a "Puff of Smoke", which is translated into Japanese as "Moyamoya". MMS is a secondary process that occurs in response to another underlying pathological process that causes stenosis of intracranial blood vessels, such as radiation. For example, an external source of radiation causes stenosis of the ICA with a compensatory response of smaller blood vessels, which then enlarge and proliferate in response and has the same "Puff of Smoke" appearance on the diagnostic cerebral angiogram (DCA). Histological findings include an irregular internal elastic lamina with luminal narrowing, hyperplasia of the tunica media, and intimal thickening with vacuolar degeneration in smooth muscle cells in the tunica media. Compensation for diminishing blood supply occurs through angiogenesis, which causes the proliferation and enlargement of smaller collateral blood vessels to increase blood supply to under-perfused areas of the brain. MMD is rare in the United States, with just 0.086 newly diagnosed cases per 100,000 individuals per year, which is approximately one per million new cases annually. Risk factors for MMD include Eastern Asian ancestry and predisposing conditions such as neurofibromatosis and Down's syndrome. Clinically, patients often present with stroke signs and symptoms from cerebral ischemia. The proliferation of collateral blood vessels within the basal ganglia can produce movement disorders. Catheter-based DCA is the current gold standard for obtaining a diagnosis. CT perfusion allows preoperative identification of ischemic vascular territories, which may be amenable to surgical intervention. MRI enables rapid detection of acute ischemic stroke using diffusion-weighted Imaging (DWI) and apparent diffusion coefficient (ADC) sequences to assess for any diffusion restriction. Non-contrast CT of the head is used to rule out acute hemorrhage in the presentation of a progressive neurological deficit. The treatment option for Moyamoya is generally surgical; medical treatment has failed to halt disease progression and neuro-interventional techniques such as attempted stenting of stenosed vessels have failed. Surgical options include direct and indirect cerebrovascular bypass.

Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome

Thalamic structure and anastomosis in different hemispheres of moyamoya disease

Recurrent Headaches and Moyamoya Syndrome in a Non-Asian Descendant: A Case Report

Clinical Management of Moyamoya Patients

Comparison between moyamoya disease and moyamoya syndrome in Israel

Moyamoya: An Update and Review

A Case Report of Moyamoya Disease Presenting as Recurrent Right-Sided Weakness

A systematic review of etiopathogenesis and treatment modalities for Moyamoya disease.

Post-infectious Moyamoya Syndrome: A Review of Existing Scientific Literature From 2000 to 2023

Moyamoya Disease Presenting As Thalamic Infarction in a Patient with Neuromyelitis Optica Spectrum Disorder

Moyamoya syndrome associated with Graves' disease: a case report and review of the literature

Abstract Number ‐ 250: Case Series of Moyamoya Patients Diagnosed on Hyperacute Imaging

A rare case of pituitary dysfunction with Moyamoya disease

Moyamoya Disease: A Rare Presentation and Literature Review

Long-term stroke risk in Moyamoya disease

An endocrine perspective of juvenile Moyamoya syndrome/disease: A literature review

Moyamoya Disease: Clinical and Radiological Characteristics in Adult Greek Patients

Navigating the Interplay of Sickle Cell Vasculopathy and Moyamoya Cerebrovascular Changes: A Case Report

Stroke and disease progression during long-term follow-up of patients with moyamoya disease older than 50 years

Moyamoya syndrome secondary to mitochondrial disease in a patient with partial trisomy 13q14 and 13q31: A novel case report and literature review

Moyamoya disease and syndrome: a review